ASTRAZENECA PHARMACEUTICALS LP
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
79
FDA:40
NMPA:20
PHILIPPINES:10
+1 more agencies
Drug Approvals
Budesonide and Formoterol Fumarate Inhalation Aerosol (III)
- Product Name
- 布地奈德福莫特罗吸入气雾剂(Ⅲ)
- Approval Number
- 国药准字HJ20240069
- Approval Date
- Jun 28, 2024
NMPA
Quetiapine Fumarate Extended-Release Tablets
- Product Name
- 富马酸喹硫平缓释片
- Approval Number
- 国药准字J20140011
- Approval Date
- Jun 16, 2020
NMPA
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (I)
- Product Name
- 安立格
- Approval Number
- J20171033
- Approval Date
- Jul 18, 2017
NMPA
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (II)
- Product Name
- 安立格
- Approval Number
- 国药准字J20171034
- Approval Date
- Jul 18, 2017
NMPA
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (III)
- Product Name
- 安立格
- Approval Number
- 国药准字J20171032
- Approval Date
- Jul 18, 2017
NMPA
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (I)
- Product Name
- 安立格
- Approval Number
- 国药准字J20171033
- Approval Date
- Jul 18, 2017
NMPA
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (II)
- Product Name
- 安立格
- Approval Number
- J20171034
- Approval Date
- Jul 18, 2017
NMPA
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (III)
- Product Name
- 安立格
- Approval Number
- J20171032
- Approval Date
- Jul 18, 2017
NMPA
Daclatasvir Hydrochloride Tablets
- Product Name
- 百立泽
- Approval Number
- J20171011
- Approval Date
- Jun 16, 2017
NMPA
Daclatasvir Hydrochloride Tablets
- Product Name
- 百立泽
- Approval Number
- 国药准字J20171011
- Approval Date
- Jun 16, 2017
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found